Literature DB >> 27188968

Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.

Rachel Davis1, Amirali Salmasi1, Christopher Koprowski1, Sinae Kim2, Young Suk Kwon1, Izak Faiena1, Neal Patel1, Sammy E Elsamra1, Isaac Yi Kim3.   

Abstract

INTRODUCTION: The presence of extracapsular extension (ECE) in prostate cancer (PCa) can influence a surgeon's decision to perform a nerve-sparing approach during radical prostatectomy (RP). Preoperatively, multiparametric MRI (mp-MRI) is often used to stage PCa. More recently, the use of mp-MRI has gained wide acceptance in fusion biopsy of the prostate. In this framework, the reported accuracy of mp-MRI has been highly variable, with data often originating from large referral centers with experienced radiologists. We sought to determine the sensitivity and specificity of mp-MRI for detecting ECE in the community.
MATERIALS AND METHODS: We reviewed a prospectively maintained database of men with PCa who had undergone RP. We recorded the prevalence of ECE at RP and determined the sensitivity, specificity, positive predictive value, and negative predictive value of MRI for detecting ECE. We assessed these values according to the D'Amico risk groups and compared the predictive value of MRI to that of the Partin tables.
RESULTS: The prevalence of ECE was 11.5%, 28.1%, and 47.1% in the low-, intermediate, and high-risk groups, respectively, with an overall prevalence of 24.1%. The overall sensitivity, specificity, positive predictive value, and negative predictive value of MRI was 12.5%, 93.1%, 36.4%, and 77.0%, respectively.
CONCLUSION: The reduction in the sensitivity of preoperative mp-MRI to determine ECE in the community setting is significant. Even with stratification using the D'Amico criteria and Partin tables, the performance of mp-MRI was not significantly improved. Because most cases of PCa are diagnosed and treated in the community, it is questionable whether mp-MRI is a suitable staging modality in the community.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic test accuracy; Imaging test; Partin table; Prostatic neoplasms; Risk assessment

Mesh:

Year:  2016        PMID: 27188968     DOI: 10.1016/j.clgc.2016.04.010

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  7 in total

1.  [PI-RADS 2.0 for Prostate MRI].

Authors:  T Franiel; M Röthke
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

2.  Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy.

Authors:  J V Hegde; D J Margolis; P-C Wang; R E Reiter; J Huang; M L Steinberg; M Kamrava
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-01-31       Impact factor: 5.554

3.  Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy.

Authors:  Eoin Dinneen; Clare Allen; Tom Strange; Daniel Heffernan-Ho; Jelena Banjeglav; Jamie Lindsay; John-Patrick Mulligan; Tim Briggs; Senthil Nathan; Ashwin Sridhar; Jack Grierson; Aiman Haider; Christos Panayi; Dominic Patel; Alex Freeman; Jonathan Aning; Raj Persad; Imran Ahmad; Lorenzo Dutto; Neil Oakley; Alessandro Ambrosi; Tom Parry; Veeru Kasivisvanathan; Francesco Giganti; Greg Shaw; Shonit Punwani
Journal:  Diagnostics (Basel)       Date:  2022-04-23

4.  Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis.

Authors:  Fan Zhang; Chen-Lu Liu; Qian Chen; Sheng-Chao Shao; Shuang-Qing Chen
Journal:  Br J Radiol       Date:  2019-10-16       Impact factor: 3.039

5.  Local staging of prostate cancer with multiparametric-MRI: accuracy and inter-reader agreement.

Authors:  Cristian Popiţa; Anca-Raluca Popiţa; Adina Andrei; Adriana Rusu; Bogdan Petruţ; Gabriel Kacso; Cătălina Bungărdean; Nicolae Bolog; Ioan Coman
Journal:  Med Pharm Rep       Date:  2020-04-22

Review 6.  Current Opinion on the Use of Magnetic Resonance Imaging in Staging Prostate Cancer: A Narrative Review.

Authors:  Jamie Michael; Kevin Neuzil; Ersan Altun; Marc A Bjurlin
Journal:  Cancer Manag Res       Date:  2022-03-01       Impact factor: 3.989

7.  Prostate shapes on pre-treatment MRI between prostate cancer patients who do and do not undergo biochemical recurrence are different: Preliminary Findings.

Authors:  Soumya Ghose; Rakesh Shiradkar; Mirabela Rusu; Jhimli Mitra; Rajat Thawani; Michael Feldman; Amar C Gupta; Andrei S Purysko; Lee Ponsky; Anant Madabhushi
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.